{"key":"op_696_DE","page":{"url":"https://us-uk.bookimed.com/clinics/country=germany/procedure=immunotherapy-for-prostate-cancer/","procedure":{"id":696,"slug":"immunotherapy-for-prostate-cancer","name":"Immunotherapy for prostate cancer","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":22,"iso":"DE","name":"Germany"},"currency":"USD","data_date":"2026-10-02"},"pages":{"clinics_url":"https://us-uk.bookimed.com/clinics/country=germany/procedure=immunotherapy-for-prostate-cancer/","cost_url":"https://us-uk.bookimed.com/clinics/country=germany/procedure=immunotherapy-for-prostate-cancer/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":9500,"to":19500,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":48000,"to":105000},"uk":{"from":14000,"to":28000},"by_technique":[{"technique":"Sipuleucel-T autologous cellular immunotherapy","technique_id":"sipuleucel-t-autologous","price_from":{"status":"missing","reason":"not_offered"},"currency":"USD","source":"not_offered","date":"2026-11-17"},{"technique":"Checkpoint inhibitor (e.g., pembrolizumab)","technique_id":"checkpoint-inhibitor","price_from":10000,"currency":"USD","source":"estimate","date":"2026-11-17"},{"technique":"Investigational vaccines and combinations","technique_id":"investigational-vaccines","price_from":12000,"currency":"USD","source":"estimate","date":"2026-11-17"}],"by_city":[{"city":"Hamburg","from":9500},{"city":"Bremen","from":9500},{"city":"Frankfurt am Main","from":9500},{"city":"Berlin","from":9000}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":6000,"to":14000},{"country_iso":"FR","from":9500,"to":19000},{"country_iso":"GB","from":14000,"to":28000},{"country_iso":"US","from":48000,"to":105000},{"country_iso":"IL","from":14000,"to":26000},{"country_iso":"TR","from":8000,"to":24000},{"country_iso":"MX","from":25000,"to":35000},{"country_iso":"CA","from":28000,"to":65000},{"country_iso":"AE","from":18000,"to":42000},{"country_iso":"TH","from":5900,"to":25000},{"country_iso":"PL","from":6000,"to":14000},{"country_iso":"KR","from":12000,"to":26000},{"country_iso":"CZ","from":9000,"to":19000},{"country_iso":"AT","from":9500,"to":20000},{"country_iso":"ES","from":6000,"to":18000},{"country_iso":"IT","from":50000,"to":80000},{"country_iso":"CN","from":9000,"to":24000},{"country_iso":"AU","from":14000,"to":29000},{"country_iso":"IN","from":9000,"to":16000},{"country_iso":"MY","from":4500,"to":13000},{"country_iso":"VN","from":8200,"to":14800},{"country_iso":"BR","from":14000,"to":22000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":80,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":3,"items":[{"id":136,"name":"Nordwest Clinic (Krankenhaus)","city":"Frankfurt am Main","rating":4.5,"reviews_count":57,"accreditations":["TÜV AG Сompany Research & Investing Certificate","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":295,"name":"Bremen-Mitte Clinic","city":"Bremen","rating":4.3,"reviews_count":41,"accreditations":["International Organization for Standardization","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":404,"name":"Bremen-Ost Clinic","city":"Bremen","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Cooperation for transparency and quality in the health service","TOP German hospital according to 2019 Focus ranking"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":1,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":119,"slug":"gamburg","name":"Hamburg","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9500,"profile":{"city_type":"Second-largest city in Germany","access":["Hamburg Airport (HAM), 9 km north of city center"],"sources":["https://en.wikipedia.org/wiki/Hamburg","https://en.wikipedia.org/wiki/Hamburg_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":352,"slug":"bremen","name":"Bremen","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9500,"profile":{"city_type":"Hanseatic port city in northern Germany","access":["Bremen Airport (BRE), 4 km south of the city"],"sources":["https://en.wikipedia.org/wiki/Bremen","https://en.wikipedia.org/wiki/Bremen_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":354,"slug":"frankfurt-am-main","name":"Frankfurt am Main","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9500,"profile":{"city_type":"Most populous city in Hesse, Germany","access":["Frankfurt Airport (FRA), 12 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Frankfurt","https://en.wikipedia.org/wiki/Frankfurt_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":23,"slug":"berlin","name":"Berlin","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9000,"profile":{"city_type":"Capital and largest city of Germany","access":["Berlin Airport (BER), 18 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Berlin","https://en.wikipedia.org/wiki/Berlin_Brandenburg_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["Minimally symptomatic metastatic castration-resistant prostate cancer","Asymptomatic metastatic castration-resistant prostate cancer with good performance status"],"contraindications":["Hypersensitivity to product components","Symptomatic or visceral metastatic disease requiring urgent therapy","Poor performance status (ECOG 2 or higher)","Inadequate venous access for leukapheresis","Active uncontrolled infection","High-dose corticosteroid or immunosuppressive therapy","Uncontrolled cardiac disease or bleeding disorder"],"operation_hours":{"min":1,"max":4,"unit":"hours","qualifier":"Per visit: apheresis about 3-4 hours, infusion about 1 hour plus observation."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":6,"max":6,"unit":"visits","qualifier":"Three cycles, each with one leukapheresis visit and one infusion visit."},"stages":[{"code":"apheresis_1","label":"First leukapheresis","after":{"min":0,"max":0,"unit":"days","qualifier":"Day 0; start of treatment."}},{"code":"infusion_1","label":"First infusion","after":{"min":3,"max":4,"unit":"days","qualifier":"Day 3-4; 3-4 days after first leukapheresis."}},{"code":"apheresis_2","label":"Second leukapheresis","after":{"min":14,"max":16,"unit":"days","qualifier":"Day 14-16; about 2 weeks after first leukapheresis."}},{"code":"infusion_2","label":"Second infusion","after":{"min":17,"max":20,"unit":"days","qualifier":"Day 17-20; 3-4 days after second leukapheresis."}},{"code":"apheresis_3","label":"Third leukapheresis","after":{"min":28,"max":32,"unit":"days","qualifier":"Day 28-32; about 2 weeks after second leukapheresis."}},{"code":"infusion_3","label":"Third infusion","after":{"min":31,"max":36,"unit":"days","qualifier":"Day 31-36; 3-4 days after third leukapheresis."}}],"qualifier":"Protocol based on sipuleucel-T, given as three cycles about 2 weeks apart."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Leukapheresis and infusions are same-day outpatient visits without overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Recovery from infusion-related symptoms after each cycle; no formal rehabilitation needed."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"After final infusion if no infusion reaction; travel between cycles is impractical due to 2-week spacing."},"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"After each apheresis or infusion; depends on infusion reactions such as fatigue, chills and fever."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity resumes once infusion-related fatigue or fever settles."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Immune response builds after the third infusion; benefit shows as survival, not PSA fall."},"result_longevity":"Median survival gain of about 4 months; not curative. Disease stays under PSA and imaging monitoring.","main_risks":["Infusion reactions: chills, fever, fatigue, nausea, headache; usually mild","Citrate-related tingling or cramps during leukapheresis","Rare cerebrovascular events"],"complication_rate_pct":{"min":90,"max":98,"unit":"percent","qualifier":"Any adverse event, similar to placebo; mostly mild infusion reactions within 1-2 days; serious events about 20-25%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Median overall survival gain vs placebo","value":4.1,"horizon":"Median follow-up about 3 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"proven"},"scars":"No surgical scars; only small needle puncture sites from intravenous access for apheresis and infusion.","pain":"Minimal pain; needle insertion for apheresis may cause mild discomfort. Back pain, joint ache or headache may occur for 1-2 days after infusion.","preparation":["Confirm castration-resistant metastatic disease","Review PSA, imaging and prior treatments","Ensure adequate venous access","Continue androgen deprivation therapy","Avoid high-dose steroids","Stay hydrated before apheresis","Check blood counts and calcium"],"recovery_timeline":[{"phase":"Day of apheresis","description":"Blood cells collected over about 3-4 hours; mild fatigue or tingling from citrate possible.","restrictions":["Avoid strenuous activity that day"]},{"phase":"Infusion day and next 1-2 days","description":"Cells infused over about 1 hour; chills, fever, fatigue or headache may occur and settle.","restrictions":["Observe for reactions after infusion","Avoid heavy exertion"]},{"phase":"Weeks 1-5","description":"Three apheresis-infusion cycles about 2 weeks apart, with normal daily life between visits.","restrictions":{"status":"missing","reason":"not_collected"}},{"phase":"After final infusion","description":"Return to routine oncology monitoring with PSA and imaging.","restrictions":{"status":"missing","reason":"not_collected"}}],"follow_up_visits":[{"purpose":"other","requirement":"routine","after":{"min":3,"max":4,"unit":"days","qualifier":"Post-infusion reaction check; repeated each cycle."}},{"purpose":"assessment","requirement":"routine","after":{"min":60,"max":90,"unit":"days","qualifier":"Clinical review with PSA, testosterone and imaging after third infusion."}},{"purpose":"result_review","requirement":"routine","after":{"min":120,"max":180,"unit":"days","qualifier":"Ongoing oncologic follow-up with PSA and imaging every few months."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that a specialist care team will look after you during your treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/prostate-cancer/treatment/","host":"nhs.uk","quote":"A specialist care team will look after you during your treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Ask whether the surgeon and the facility use a surgical safety checklist, which can reduce complications","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Do the surgeon and his/her facility use a safety checklist?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"You may have a severe allergic reaction.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Stroke","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"Sipuleucel-T can cause stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Prostate-specific antigen (PSA) test","aliases":["Prostate-specific antigen (PSA) test","PSA","PSA test","prostate-specific antigen","PSA blood test"],"kind":"lab","origin":[{"field":"preparation","text":"Review PSA, imaging and prior treatments"},{"field":"initial_assessment_documents","text":"PSA and testosterone results over time"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Check blood counts and calcium"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Calcium blood test","aliases":["Calcium blood test","calcium","serum calcium","blood calcium"],"kind":"lab","origin":[{"field":"preparation","text":"Check blood counts and calcium"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Testosterone blood test","aliases":["Testosterone blood test","testosterone","testosterone level","serum testosterone"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PSA and testosterone results over time"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"PSMA PET-CT scan","aliases":["PSMA PET-CT scan","PSMA PET-CT","PSMA PET scan","PET-CT","PSMA PET"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"PSMA PET-CT or bone scan report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Bone scan","aliases":["Bone scan","skeletal scintigraphy","bone scintigraphy"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"PSMA PET-CT or bone scan report"}],"what_it_checks":{"text":"Looks for prostate cancer that may have spread to the bones","source":{"url":"https://www.nice.org.uk/guidance/NG131/chapter/recommendations","host":"nice.org.uk","quote":"offer an isotope bone scan if symptoms or PSA trends are suggestive of metastases.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"case","text":"If you have symptoms or PSA trends suggesting metastases","source":{"url":"https://www.nice.org.uk/guidance/NG131/chapter/recommendations","host":"nice.org.uk","quote":"offer an isotope bone scan if symptoms or PSA trends are suggestive of metastases.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T7","name":"Prostate MRI","aliases":["Prostate MRI","MRI of the prostate","prostate magnetic resonance imaging"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Prostate or pelvic MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pelvic MRI","aliases":["Pelvic MRI","MRI of the pelvis","pelvis MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Prostate or pelvic MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"MSI/MMR test","aliases":["MSI/MMR test","MSI test","MMR test","microsatellite instability test","mismatch repair test"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"MSI/MMR or genomic test report (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"After each apheresis or infusion; depends on infusion reactions such as fatigue, chills and fever."},"complication_rate_pct":{"min":90,"max":98,"unit":"percent","qualifier":"Any adverse event, similar to placebo; mostly mild infusion reactions within 1-2 days; serious events about 20-25%."},"contraindications":["Hypersensitivity to product components","Symptomatic or visceral metastatic disease requiring urgent therapy","Poor performance status (ECOG 2 or higher)","Inadequate venous access for leukapheresis","Active uncontrolled infection","High-dose corticosteroid or immunosuppressive therapy","Uncontrolled cardiac disease or bleeding disorder"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Leukapheresis and infusions are same-day outpatient visits without overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity resumes once infusion-related fatigue or fever settles."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Immune response builds after the third infusion; benefit shows as survival, not PSA fall."},"fly_home_after_days":{"min":1,"max":2,"unit":"days","qualifier":"After final infusion if no infusion reaction; travel between cycles is impractical due to 2-week spacing."},"follow_up_visits":[{"purpose":"other","after":{"min":3,"max":4,"unit":"days","qualifier":"Post-infusion reaction check; repeated each cycle."},"requirement":"routine"},{"purpose":"assessment","after":{"min":60,"max":90,"unit":"days","qualifier":"Clinical review with PSA, testosterone and imaging after third infusion."},"requirement":"routine"},{"purpose":"result_review","after":{"min":120,"max":180,"unit":"days","qualifier":"Ongoing oncologic follow-up with PSA and imaging every few months."},"requirement":"routine"}],"indications":["Minimally symptomatic metastatic castration-resistant prostate cancer","Asymptomatic metastatic castration-resistant prostate cancer with good performance status"],"main_risks":["Infusion reactions: chills, fever, fatigue, nausea, headache; usually mild","Citrate-related tingling or cramps during leukapheresis","Rare cerebrovascular events"],"pain":"Minimal pain; needle insertion for apheresis may cause mild discomfort. Back pain, joint ache or headache may occur for 1-2 days after infusion.","preparation":["Confirm castration-resistant metastatic disease","Review PSA, imaging and prior treatments","Ensure adequate venous access","Continue androgen deprivation therapy","Avoid high-dose steroids","Stay hydrated before apheresis","Check blood counts and calcium"],"recovery_timeline":[{"phase":"Day of apheresis","description":"Blood cells collected over about 3-4 hours; mild fatigue or tingling from citrate possible.","restrictions":["Avoid strenuous activity that day"]},{"phase":"Infusion day and next 1-2 days","description":"Cells infused over about 1 hour; chills, fever, fatigue or headache may occur and settle.","restrictions":["Observe for reactions after infusion","Avoid heavy exertion"]},{"phase":"Weeks 1-5","description":"Three apheresis-infusion cycles about 2 weeks apart, with normal daily life between visits.","restrictions":[]},{"phase":"After final infusion","description":"Return to routine oncology monitoring with PSA and imaging.","restrictions":[]}],"rehabilitation_days":{"min":0,"max":2,"unit":"days","qualifier":"Recovery from infusion-related symptoms after each cycle; no formal rehabilitation needed."},"result_longevity":"Median survival gain of about 4 months; not curative. Disease stays under PSA and imaging monitoring.","revision_rate_pct":null,"scars":"No surgical scars; only small needle puncture sites from intravenous access for apheresis and infusion.","sessions_or_stages":{"sessions":{"min":6,"max":6,"unit":"visits","qualifier":"Three cycles, each with one leukapheresis visit and one infusion visit."},"stages":[{"code":"apheresis_1","label":"First leukapheresis","after":{"min":0,"max":0,"unit":"days","qualifier":"Day 0; start of treatment."}},{"code":"infusion_1","label":"First infusion","after":{"min":3,"max":4,"unit":"days","qualifier":"Day 3-4; 3-4 days after first leukapheresis."}},{"code":"apheresis_2","label":"Second leukapheresis","after":{"min":14,"max":16,"unit":"days","qualifier":"Day 14-16; about 2 weeks after first leukapheresis."}},{"code":"infusion_2","label":"Second infusion","after":{"min":17,"max":20,"unit":"days","qualifier":"Day 17-20; 3-4 days after second leukapheresis."}},{"code":"apheresis_3","label":"Third leukapheresis","after":{"min":28,"max":32,"unit":"days","qualifier":"Day 28-32; about 2 weeks after second leukapheresis."}},{"code":"infusion_3","label":"Third infusion","after":{"min":31,"max":36,"unit":"days","qualifier":"Day 31-36; 3-4 days after third leukapheresis."}}],"qualifier":"Protocol based on sipuleucel-T, given as three cycles about 2 weeks apart."},"success":{"metric":"Median overall survival gain vs placebo","value":4.1,"unit":"months","horizon":"Median follow-up about 3 years","population":"Asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer","evidence_status":"proven"},"techniques":[{"name":"Sipuleucel-T autologous cellular immunotherapy","suits_whom":"Asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.","recovery":"Outpatient; mild infusion reactions for 1-2 days per cycle."},{"name":"Checkpoint inhibitor (e.g., pembrolizumab)","suits_whom":"Biomarker-selected advanced disease such as MSI-high/dMMR or TMB-high tumors.","recovery":"Outpatient infusion about every 3-6 weeks; immune-related side effects need monitoring."},{"name":"Investigational vaccines and combinations","suits_whom":"Selected patients within clinical trials.","recovery":"Trial-specific schedule and monitoring."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":1,"max":4,"unit":"hours","qualifier":"Per visit: apheresis about 3-4 hours, infusion about 1 hour plus observation."},"initial_assessment_documents":["Prostate biopsy pathology report with Gleason score","PSA and testosterone results over time","PSMA PET-CT or bone scan report","Prostate or pelvic MRI report","Prior treatment summary including hormone therapy","MSI/MMR or genomic test report (if available)"],"travel_trips":{"min":1,"max":1,"one_trip_possible":true,"qualifier":"Full three-cycle course fits one stay of about 5 weeks."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that a specialist care team will look after you during your treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/prostate-cancer/treatment/","host":"nhs.uk","quote":"A specialist care team will look after you during your treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Expect two consultations with the treating surgeon before any surgery, which also gives you time to reconsider","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You should have 2 consultations with the surgeon treating you before any surgery.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Ask whether the surgeon and the facility use a surgical safety checklist, which can reduce complications","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Do the surgeon and his/her facility use a safety checklist?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"A price that sounds too good to be true probably is","scope":"treatment_abroad","source":{"url":"https://www.plasticsurgery.org/news/articles/will-economic-uncertainty-drive-more-patients-overseas-for-plastic-surgery-what-to-consider-and-how-to-stretch-your-dollar-back-home","host":"plasticsurgery.org","quote":"If the price sounds too good to be true, it probably is.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"You may have a severe allergic reaction.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Stroke","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"Sipuleucel-T can cause stroke.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You already received hormone therapy for recurrent cancer","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq","host":"cancer.gov","quote":"- Chemotherapy for patients already treated with hormone therapy.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"sipuleucel-t-autologous","name":"Sipuleucel-T autologous cellular immunotherapy","how_it_works":{"text":"Dendritic cell vaccines stimulate your immune system against tumor cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"Dendritic cell vaccines stimulate your immune system to respond to an antigen on tumor cells.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"checkpoint-inhibitor","name":"Checkpoint inhibitor (e.g., pembrolizumab)","how_it_works":{"text":"Checkpoint inhibitors help the immune system target prostate cancer","source":{"url":"https://www.cancer.gov/types/prostate/research","host":"cancer.gov","quote":"Vaccines and checkpoint inhibitors are two types of immunotherapy being tested in prostate cancer.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"investigational-vaccines","name":"Investigational vaccines and combinations","how_it_works":{"text":"Some vaccines are made from antigens found on many people's cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"They may be made from tumor-associated antigens that are found on cancer cells of many people with a specific type of cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Prostate-specific antigen (PSA) test","aliases":["Prostate-specific antigen (PSA) test","PSA","PSA test","prostate-specific antigen","PSA blood test"],"kind":"lab","origin":[{"field":"preparation","text":"Review PSA, imaging and prior treatments"},{"field":"initial_assessment_documents","text":"PSA and testosterone results over time"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Complete blood count","aliases":["Complete blood count","CBC","full blood count","blood counts"],"kind":"lab","origin":[{"field":"preparation","text":"Check blood counts and calcium"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"Calcium blood test","aliases":["Calcium blood test","calcium","serum calcium","blood calcium"],"kind":"lab","origin":[{"field":"preparation","text":"Check blood counts and calcium"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Testosterone blood test","aliases":["Testosterone blood test","testosterone","testosterone level","serum testosterone"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"PSA and testosterone results over time"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"PSMA PET-CT scan","aliases":["PSMA PET-CT scan","PSMA PET-CT","PSMA PET scan","PET-CT","PSMA PET"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"PSMA PET-CT or bone scan report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Bone scan","aliases":["Bone scan","skeletal scintigraphy","bone scintigraphy"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"PSMA PET-CT or bone scan report"}],"what_it_checks":{"text":"Looks for prostate cancer that may have spread to the bones","source":{"url":"https://www.nice.org.uk/guidance/NG131/chapter/recommendations","host":"nice.org.uk","quote":"offer an isotope bone scan if symptoms or PSA trends are suggestive of metastases.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"type":"case","text":"If you have symptoms or PSA trends suggesting metastases","source":{"url":"https://www.nice.org.uk/guidance/NG131/chapter/recommendations","host":"nice.org.uk","quote":"offer an isotope bone scan if symptoms or PSA trends are suggestive of metastases.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"test_prep":null},{"id":"T7","name":"Prostate MRI","aliases":["Prostate MRI","MRI of the prostate","prostate magnetic resonance imaging"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Prostate or pelvic MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pelvic MRI","aliases":["Pelvic MRI","MRI of the pelvis","pelvis MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Prostate or pelvic MRI report"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"MSI/MMR test","aliases":["MSI/MMR test","MSI test","MMR test","microsatellite instability test","mismatch repair test"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"MSI/MMR or genomic test report (if available)"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"sipuleucel-t-autologous","name":"Sipuleucel-T autologous cellular immunotherapy","how_it_works":{"id":"H1","text":"Dendritic cell vaccines stimulate your immune system against tumor cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"Dendritic cell vaccines stimulate your immune system to respond to an antigen on tumor cells.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.","price_from":{"status":"missing","reason":"not_offered"},"recovery":"Outpatient; mild infusion reactions for 1-2 days per cycle."},{"id":"checkpoint-inhibitor","name":"Checkpoint inhibitor (e.g., pembrolizumab)","how_it_works":{"id":"H1","text":"Checkpoint inhibitors help the immune system target prostate cancer","source":{"url":"https://www.cancer.gov/types/prostate/research","host":"cancer.gov","quote":"Vaccines and checkpoint inhibitors are two types of immunotherapy being tested in prostate cancer.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Biomarker-selected advanced disease such as MSI-high/dMMR or TMB-high tumors.","price_from":10000,"recovery":"Outpatient infusion about every 3-6 weeks; immune-related side effects need monitoring."},{"id":"investigational-vaccines","name":"Investigational vaccines and combinations","how_it_works":{"id":"H1","text":"Some vaccines are made from antigens found on many people's cancer cells","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/cancer-treatment-vaccines","host":"cancer.gov","quote":"They may be made from tumor-associated antigens that are found on cancer cells of many people with a specific type of cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Selected patients within clinical trials.","price_from":12000,"recovery":"Trial-specific schedule and monitoring."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You already received hormone therapy for recurrent cancer","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/prostate/patient/prostate-treatment-pdq","host":"cancer.gov","quote":"- Chemotherapy for patients already treated with hormone therapy.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":37}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British passport holders can travel to the Schengen area, which includes Germany, without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area , which includes Germany, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must have an expiry date at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V3","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport should be valid for at least 3 months beyond your period of stay when transiting a Schengen country","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"Your passport should be valid for at least 3 months beyond your period of stay if you plan on transiting a Schengen country.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"medicines","audience":"all","volatile":false,"text":"For medications Germany classifies as narcotics, you may only carry a 30-day supply","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"For medications that Germany classifies as narcotics, you may only carry a 30-day supply.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"ghic","audience":"uk","volatile":false,"text":"To get medically necessary state healthcare in Germany, UK travelers need a GHIC or an EHIC","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Germany, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Germany","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["azerbaijan","china","greece","india","israel","latvia","malaysia","mexico","republic-of-korea","spain","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.42,"count":98,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy for prostate cancer in Germany typically costs from _op_696_price_from_ to _op_696_price_to_. Final expenses depend on the specific protocol, cycles required, and diagnostic depth, such as PET/CT imaging. Patients save around _price_percent_discount_% compared to the United States, where average costs are _price_compare_US_average_. Quotes usually include specialist consultations, tumor board reviews, drug administration, and nursing monitoring during infusions.</p>\n\n<ul>\n<li><strong>Dendritic cell therapy:</strong> Typically ranges from 20-40% of the total treatment budget.</li>\n<li><strong>Checkpoint inhibitors:</strong> Maintenance drugs like Keytruda often require monthly budgeting for long-term care.</li>\n<li><strong>CAR T-cell therapy:</strong> This highly specialized genetic modification represents the most premium treatment tier.</li>\n<li><strong>Regional hubs:</strong> Main medical hubs for oncological care include Frankfurt am Main, Hamburg, and Bremen.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Choosing a research-driven facility offers superior value for complex prostate cases. Asklepios Hospital Barmbek is ranked among the top 10 for prostate cancer by Focus magazine. Nordwest Clinic in Frankfurt provides unique access to five separate research institutes. These institutions offer advanced molecular diagnostics. This ensures patients receive the most precise drug therapy for their specific tumor profile.</p>","faq":[{"q":"What is immunotherapy for prostate cancer?","a":"<p>Immunotherapy for prostate cancer uses the body's immune system to identify and destroy malignant cells. In Germany, this approach typically treats advanced or metastatic stages that resist hormone therapy. Specialists use personalized vaccines like Sipuleucel-T or checkpoint inhibitors such as Pembrolizumab for tumors with specific genetic biomarkers.</p> <ul> <li><strong>Treatment types:</strong> Options include personalized cancer vaccines and targeted immune checkpoint inhibitors.</li> <li><strong>Eligibility criteria:</strong> Therapy is often reserved for metastatic castration-resistant prostate cancer (mCRPC).</li> <li><strong>Genetic biomarkers:</strong> Checkpoint inhibitors work best for patients with MSI-H or dMMR mutations.</li> <li><strong>Medical centers:</strong> German facilities like Nordwest Clinic utilize molecular diagnostics for targeted therapy.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers prioritize molecular diagnostics before starting immunotherapy. Clinics like Nordwest Clinic or Bremen-Mitte use these tests to find tumor-specific markers. This ensures patients only receive high-cost immunotherapy if their specific cancer type is likely to respond. This precision-first approach helps avoid ineffective treatments and manages the complex costs associated with these advanced drugs.</p> <p><strong>Patient Consensus:</strong> Success is highly selective and usually follows hormone therapy or radiation. Patients emphasize the importance of asking for biomarker testing to confirm if immunotherapy will realistically prolong survival.</p>"},{"q":"Does immunotherapy work for prostate cancer?","a":"<p>Immunotherapy effectively treats advanced prostate cancer, primarily for cases resistant to hormone therapy. Specialized vaccines like Sipuleucel-T improve survival in metastatic patients. While checkpoint inhibitors show limited general success, they produce significant results for patients with specific genetic markers like microsatellite instability-high or CDK12 mutations.</p> <ul> <li><strong>Treatment eligibility:</strong> Most effective for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer.</li> <li><strong>Genetic biomarkers:</strong> Success depends on mismatch repair deficiency or microsatellite instability-high molecular profiles.</li> <li><strong>Combined protocols:</strong> German centers frequently pair immunotherapy with radiation, hormone therapy, or PARP inhibitors.</li> <li><strong>Advanced diagnostics:</strong> Leading clinics utilize molecular diagnostics to identify patients likely to benefit.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers like Nordwest Clinic and Bremen-Mitte emphasize a research-driven approach by integrating immunotherapy into multidisciplinary trials. While the procedure costs _op_696_price_from_ to _op_696_price_to_, the real value lies in their focus on anticancer vaccines in targeted therapy. This specific specialization, combined with TÜV and ISO certifications, ensures patients receive experimental combinations not always available in standard hospital settings.</p> <p><strong>Patient Consensus:</strong> Patients emphasize requesting MSI and dMMR biomarker testing early to confirm eligibility. Many noted that while common responses were modest, those with the correct genetic profile experienced dramatic improvements.</p>"},{"q":"Can immunotherapy be used for metastatic (stage 4) prostate cancer?","a":"<p>Immunotherapy effectively treats metastatic stage 4 prostate cancer for specific patients identified through genetic biomarker testing. While prostate tumors are often immune-cold, drugs like pembrolizumab show success in cases with high microsatellite instability or mismatch repair deficiency. German oncology centers utilize these targeted approaches based on molecular profiling.</p> <ul> <li><strong>Eligibility criteria:</strong> Requires biomarkers like microsatellite instability (MSI-H) or high tumor mutational burden (TMB-H).</li> <li><strong>Treatment types:</strong> Options include checkpoint inhibitors like pembrolizumab or personalized cancer vaccines for eligible patients.</li> <li><strong>Diagnostic process:</strong> Molecular testing is essential to identify genetic mutations that respond to immune-based therapies.</li> <li><strong>Clinical setting:</strong> Advanced cases may access innovative protocols through clinical trials at specialized German institutes.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Germany's top oncology centers, such as Nordwest Clinic, integrate five separate research institutes to advance immunotherapy access. While the US average for these treatments is _price_compare_US_average_, German facilities offer similar biomarker-driven protocols with a _price_percent_discount_% savings margin. This infrastructure allows specialists like Prof. Dr. Viola Fox to match patients with specific genetic profiles to the newest available therapies quickly.</p> <p><strong>Patient Consensus:</strong> Many patients emphasize requesting biomarker testing early in the treatment process to avoid missing eligibility. They often find that specialized centers in Germany provide more detailed molecular profiles than standard hospitals.</p>"},{"q":"What are the side effects of immunotherapy for prostate cancer?","a":"<p>Immunotherapy for prostate cancer primarily causes fatigue, skin rashes, and flu-like symptoms. While often milder than chemotherapy, these treatments can trigger overactive immune responses. Significant side effects like colitis or pneumonitis occur when the immune system impacts healthy organs like the lungs or colon.</p> <ul> <li><strong>Systemic reactions:</strong> Extreme fatigue and fever commonly occur shortly after treatment sessions.</li> <li><strong>Gormonal changes:</strong> Immune-mediated inflammation may cause thyroid dysfunction or permanent hormone deficiencies.</li> <li><strong>Gastrointestinal risks:</strong> Persistent diarrhea can signal serious colon inflammation requiring immediate medical intervention.</li> <li><strong>Management protocols:</strong> Specialized German centers use corticosteroids to quickly cool down treatment-induced inflammation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers like Nordwest Clinic often combine immunotherapy with molecular diagnostics to predict reactions. Dr. Viola Fox in Solingen tracks genetic markers to personalize these therapies. This approach helps identify patients at higher risk for delayed immune-mediated side effects before they escalate.</p> <p><strong>Patient Consensus:</strong> Many patients find daily fatigue more persistent than expected. They highlight that skin rashes or joint aches are often the first visible signs of a strong immune response.</p>"},{"q":"Why is Germany considered a leading destination for prostate-cancer immunotherapy?","a":"<p>Germany leads in prostate cancer immunotherapy due to specific laws allowing early access to innovative biotherapies like dendritic cell vaccines. Specialized centers utilize advanced PSMA-targeted theranostics and personalized protocols, providing treatments often unavailable or restricted in other countries for advanced-stage or metastatic patients.</p> <ul> <li><strong>Regulatory advantage:</strong> The German Medicines Act permits manufacturing customized biotherapies for individual patients.</li> <li><strong>Advanced diagnostics:</strong> Clinics use PSMA PET/CT scans to guide precise Lutetium-177 or Actinium-225 therapies.</li> <li><strong>Specialized infrastructure:</strong> Facilities like Nordwest Clinic feature dedicated research institutes for anticancer vaccine development.</li> <li><strong>Expert oncologists:</strong> Specialists like Dr. Viola Fox combine 15 years experience with molecular genetics expertise.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers often outperform counterparts by embedding research institutes directly within the hospital. For instance, Nordwest Clinic houses 5 separate research institutes. This structure lets doctors move laboratory breakthroughs into clinical practice months faster than traditional hospital systems.</p> <p><strong>Patient Consensus:</strong> Patients value the speed of starting treatment compared to long waitlists in their home countries. Many highlight the peace of mind provided by well-coordinated multidisciplinary teams at specialized German oncology centers.</p>"},{"q":"Which clinics in Germany offer immunotherapy for prostate cancer?","a":"<p>Top German medical centers like Nordwest Clinic in Frankfurt and Bremen-Mitte Clinic offer advanced immunotherapy for prostate cancer using checkpoint inhibitors and personalized tumor vaccines. These facilities often hold German Cancer Society certifications and Focus magazine rankings for high-quality oncology care and molecular diagnostics.</p> <ul> <li><strong>Specialized facilities:</strong> Nordwest Clinic features 5 research institutes focused on innovative anticancer vaccines.</li> <li><strong>Expert physicians:</strong> Dr. Viola Fox at Solingen Medical Center specializes in targeted immunotherapy and oncology.</li> <li><strong>Hospital standards:</strong> Bremen-Mitte Clinic is ISO-certified and part of the respected Nord Klinik Allianz.</li> <li><strong>Advanced diagnostics:</strong> Leading centers require molecular testing to determine patient eligibility for specific immunotherapies.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many private centers offer dendritic cell vaccines, Bookimed data shows that established academic centers like Nordwest Clinic handle a higher volume of research-based protocols. These clinics integrate immunotherapies with standard care more frequently than standalone private labs, which is crucial for managing advanced prostate cancer stages.</p> <p><strong>Patient Consensus:</strong> Experienced patients recommend prioritizing University Hospitals over smaller local clinics to ensure access to experimental treatments. Most emphasize the importance of requesting molecular testing before committing to any immunotherapy program.</p>"},{"q":"Can immunotherapy be combined with other treatments for prostate cancer?","a":"<p>Immunotherapy for prostate cancer is frequently combined with hormone therapy, chemotherapy, and radiation to overcome tumor resistance. In German oncology centers, specialists use these multi-modal strategies to transform `cold` tumors into immune-responsive ones, significantly improving outcomes for patients with metastatic castration-resistant prostate cancer.</p> <ul> <li><strong>Treatment synergy:</strong> Combining immunotherapy with hormone therapy helps bypass tumor-shielding mechanisms effectively.</li> <li><strong>Advanced sequencing:</strong> Doctors often introduce immunotherapy after standard treatments if cancer progression occurs.</li> <li><strong>Biomarker testing:</strong> Success depends on MSI-high or dMMR status to confirm treatment compatibility.</li> <li><strong>Multidisciplinary approach:</strong> German tumor boards integrate targeted therapy and vaccines for aggressive cases.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics like Nordwest Clinic and Bremen-Mitte emphasize anticancer vaccines alongside traditional immunotherapy. Data suggests that patients benefit most from these combinations when treated at facilities with ISO and TÜV certifications. These clinics often utilize 3D ultrasound and molecular diagnostics to monitor real-time therapy response.</p> <p><strong>Patient Consensus:</strong> Patients find that combination therapy is the standard for advanced stages rather than a standalone option. Many advise seeking a multidisciplinary tumor board to understand how adding immunotherapy might impact fatigue or urinary symptoms.</p>"},{"q":"Which hospitals in Germany are top-rated for neurosurgery?","a":"<p>Germany features some of the worlds most prestigious neurosurgery departments, led by Charité – Universitätsmedizin Berlin and University Hospital Heidelberg. These centers excel in treating complex brain tumors and cerebrovascular disorders. They utilize advanced technologies like intraoperative MRI and computer-assisted neuronavigation to maximize procedural success.</p> <ul> <li><strong>Charité Berlin:</strong> Performs 5,000+ surgeries annually. Led by renowned neurosurgeon Dr. Peter Vajkoczy.</li> <li><strong>Medical Center Solingen:</strong> Dr. Ralf Buhl has performed 4,000+ procedures, including minimally invasive spine surgery.</li> <li><strong>Asklepios Nord Clinic:</strong> Features Germany's only two-sided intraoperative MRI for real-time surgical precision during tumor removals.</li> <li><strong>Nordwest Clinic:</strong> Recognized by Newsweek as a leading hospital for innovations in 3D ultrasound technology.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data shows that choosing high-volume centers often leads to more conservative treatment recommendations. At Medical Center Solingen, which treats 60,000+ patients yearly, surgeons frequently suggest physiotherapy over immediate surgery if risks appear high. This volume-based expertise ensures patients only undergo operations when statistically necessary for recovery.</p> <p><strong>Patient Consensus:</strong> Patients note that German specialists are very cautious and will explain all risks before proceeding. Many emphasize the comfort of modern facilities, though some mention that having a translator is helpful for navigating administrative paperwork.</p>"},{"q":"What are the reported success rates for high-complexity neurosurgery in Germany?","a":"<p>High-complexity neurosurgery in Germany demonstrates exceptional safety. Spinal fusions reach a 99% success rate. Primary brain tumor resections maintain a 97% survival rate. Functional independence is high. Over 82% of patients discharge directly home after treatment. German centers prioritize preserving neurological function using advanced mapping.</p> <ul> <li><strong>Tumor resection:</strong> Surgeons achieve gross total resection in 87.2% of brain metastasis cases.</li> <li><strong>Vascular success:</strong> Unruptured aneurysm treatments show a 98.7% survival rate in German hospitals.</li> <li><strong>Neurological improvement:</strong> Nearly 43% of patients see functional score gains after complex resections.</li> <li><strong>Surgical safety:</strong> Spinal procedures maintain a 98–99% survival rate across major surgical centers.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume surgeons like Dr. Uwe Kehler at Asklepios Altona Clinic perform 2,000+ operations annually. Data shows these experts maintain success rates up to 90% for the most complex cerebral tumors. Choosing a specialist with 4,000+ personal surgeries, such as Dr. Ralf Buhl, ensures technical precision gathered over decades of practice.</p> <p><strong>Patient Consensus:</strong> Patients note that German surgeons often prioritize physical function over aggressive tumor removal. It is important to write down all questions in advance to make the most of short consultations with busy professors.</p>"},{"q":"What advanced technologies are routinely available in German neurosurgical clinics?","a":"<p>German neurosurgical clinics routinely integrate high-precision digital tools and real-time imaging into surgical practice. Core technologies include computer-assisted neuronavigation for brain and spinal procedures. Facilities like Asklepios Nord Clinic use intraoperative MRI to verify tumor removal in real time. These systems provide a 3D GPS for surgeons.</p> <ul> <li><strong>Neuronavigation:</strong> Provides 3D visualization and real-time instrument tracking for sub-millimeter surgical precision.</li> <li><strong>Intraoperative imaging:</strong> Systems like iMRI and O-arm CT allow immediate verification of successful resection.</li> <li><strong>Neuromonitoring:</strong> Tracks motor and sensory functions during surgery to protect the nervous system.</li> <li><strong>Fluorescence diagnostics:</strong> Uses 5-ALA dye to illuminate tumor borders for more complete removal.</li> <li><strong>Robotic assistance:</strong> Systems like Da Vinci enhance dexterity for complex minimally invasive procedures.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume centers like Charité – Universitätsmedizin Berlin perform 4,000+ neurosurgeries annually, creating a data-rich environment for refining robotic protocols. Medical Center in Solingen offers specialized packages for herniated disc surgery including preoperative diagnostics. This volume allows German clinics to negotiate better rates for consumables, keeping advanced tech accessible.</p> <p><strong>Patient Consensus:</strong> Patients note that modern German clinics significantly reduce recovery times compared to older surgical methods. Many describe the experience as less painful due to smaller incisions and highly competent staff who explain every technical risk clearly.</p>"},{"q":"What specialist training do practicing neurosurgeons in Germany complete?","a":"<p>Neurosurgeons in Germany must complete 6 years of specialized residency training after medical school. This structured program includes intensive care, clinical practice, and a mandatory surgical log. Candidates then pass a state board exam to earn the title Facharzt für Neurochirurgie.</p> <ul> <li><strong>Clinical residency:</strong> Requires 48 to 72 months of dedicated neurosurgical practice.</li> <li><strong>Intensive care:</strong> Includes mandatory 6-month rotation in a neurosurgical intensive care unit.</li> <li><strong>Surgical log:</strong> Surgeons document hundreds of procedures, including craniotomies and spinal surgeries.</li> <li><strong>Board examination:</strong> Candidates must pass a state-administered oral and practical medical assessment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German neurosurgery training emphasizes high-volume surgical experience. For example, Dr. Ralf Buhl at Medical Center in Solingen has performed 4,000+ surgeries. Dr. Jürgen Kiwit at Meoclinic Hospital brings 25+ years of expertise. This rigorous system ensures that specialists at major centers manage complex cases with proven precision.</p> <p><strong>Patient Consensus:</strong> Patients feel confident knowing their doctors underwent years of strict, state-monitored training. Many note that the detailed documentation of a surgeon's past procedures provides significant peace of mind before surgery.</p>"},{"q":"What language and licensure requirements apply to international surgeons aiming to train or observe neurosurgery cases in Germany?","a":"<p>International neurosurgeons must meet strict language and licensure standards to train or observe in Germany. Training requires a full medical license or temporary permit. Observers need hospital-specific approval. Both paths demand high-level German proficiency to participate in clinical discussions and follow complex surgical protocols safely.</p> <ul> <li><strong>Language proficiency:</strong> General German B2 and medical C1 (Fachsprachprüfung) are mandatory for clinical training.</li> <li><strong>Clinical licensure:</strong> Surgeons need Approbation for permanent practice or Berufserlaubnis for temporary supervised training.</li> <li><strong>Observation status:</strong> A Hospitation allows observing surgeries without medical responsibility or a formal license.</li> <li><strong>Credential evaluation:</strong> Non-EU graduates often face a 3–6 month process to verify their medical degrees.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics with high patient volumes, like Nordwest Clinic or Asklepios Nord, often prioritize candidates who have already secured their preliminary document evaluation. Our data shows that professors like Dr. Uwe Kehler and Dr. Paul Kremer manage thousands of cases annually. Demonstrating German B2 level early can bypass many bureaucratic delays in these busy departments.</p> <p><strong>Patient Consensus:</strong> Patients note that the language barrier is significant. They emphasize that while some international staff help, having a translator or a German-speaking doctor is vital for clear communication.</p>"},{"q":"Does Germany have enough neurosurgeons to handle both domestic and international patient volumes?","a":"<p>Germany maintains the highest density of neurosurgeons in Europe with 2.94 specialists per 100,000 residents. This robust workforce easily manages international volumes through 184 dedicated departments. Key facilities like Charite Berlin perform 4,000+ surgeries annually. High specialist availability ensures additional capacity for complex global cases.</p> <ul> <li><strong>Specialist density:</strong> Germany has 2.94 neurosurgeons per 100,000 people, doubling the European average.</li> <li><strong>Clinical infrastructure:</strong> Over 182 dedicated neurosurgical departments provide widespread geographic access across Germany.</li> <li><strong>Surgical expertise:</strong> Prof. Dr. Peter Vajkoczy at Charite Berlin leads over 4,000 annual procedures.</li> <li><strong>Advanced technology:</strong> Facilities like Asklepios Nord Clinic utilize intraoperative MRI and computerized neuronavigation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Germany has high specialist numbers, top-tier professors like Dr. Ralf Buhl or Dr. Uwe Kehler are often concentrated in major hubs like Hamburg or Solingen. Our data shows these high-volume centers actually offer faster access for international patients than smaller clinics. Large academic hospitals maintain dedicated tracks for complex cases, effectively bypassing local capacity bottlenecks found in rural areas.</p> <p><strong>Patient Consensus:</strong> Patients often note that while surgeons are highly professional, clear communication about reports can sometimes take time. One patient mentioned that recovery periods in German clinics are now much shorter and less painful than in previous decades.</p>"}],"h2":[{"text":"How Much Does Immunotherapy for prostate cancer Cost in Germany?","kind":"content"},{"text":"Your Benefits and Guarantees with Bookimed","kind":"content"},{"text":"Your personal Bookimed medical coordinator","kind":"content"},{"text":"Discover the Best Immunotherapy for prostate cancer Clinics in Germany: 3 Verified Options and Prices","kind":"content"},{"text":"Immunotherapy for prostate cancer Overview in Germany","kind":"content"},{"text":"Our Doctors","kind":"content"},{"text":"Video Stories from Bookimed Patients","kind":"ui"},{"text":"Reviews about Bookimed: Discover Patients' Insights","kind":"ui"},{"text":"Share this content","kind":"ui"},{"text":"FAQ about Immunotherapy for prostate cancer in Germany","kind":"content"},{"text":"Get a free consultation","kind":"ui"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}